Cartesian Therapeutics In...

17.58
-1.26 (-6.69%)
At close: Mar 03, 2025, 3:59 PM
17.50
-0.46%
After-hours: Mar 03, 2025, 04:00 PM EST

Cartesian Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Net Income -219.71M 35.38M -25.69M -68.88M -55.35M -65.34M -65.32M -36.21M -25.17M -12.88M
Depreciation & Amortization 1.55M 1.29M 1.25M 734K 2.03M 975K 750K 802K 1.04M 864K
Stock-Based Compensation 22.52M 11.19M 7.72M 5.42M n/a n/a n/a n/a n/a 1.22M
Other Working Capital 1.23M -64.71M -45.5M 94.46M 1.12M -265K 9.3M 9.91M -87K -1.48M
Other Non-Cash Items 158.5M 2.29M 2.13M 1.75M 16.02M 8.45M 9.09M 830K 2.81M 193K
Deferred Income Tax -19M -21.4M 2.4M 10.85M n/a n/a n/a n/a n/a n/a
Change in Working Capital 4.97M -60.38M -48.19M 85M -4.48M -781K 7.12M 13.2M 427K -2.09M
Operating Cash Flow -51.16M -31.63M -60.38M 34.88M -51.44M -59.16M -52.04M -19.68M -22.46M -12.69M
Capital Expenditures -206K -1.2M -1.08M -815K -47K -884K -733K -586K -1.16M -227K
Acquisitions 6.56M n/a n/a 74K 122K 99K 4K 2K n/a n/a
Purchase of Investments n/a -33.5M -32.45M n/a -18.19M -15.6M -61.53M -28.42M n/a n/a
Sales Maturities Of Investments 28.25M 19.7M 16.4M n/a 18.34M 41.66M 60.16M n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a n/a n/a n/a 6.9M -3.52M n/a
Investing Cash Flow 34.61M -15M -17.14M -741K 229K 25.27M -2.1M -22.1M -4.68M -227K
Debt Repayment -27.46M n/a n/a 5.42M -2.8M n/a 8.02M n/a 11.43M 4.49M
Common Stock Repurchased -6.17M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 20.48M 235K 939K -3.37M 70.18M 697K 886K -3.95M 32.37M 20.28M
Financial Cash Flow -13.14M 39.22M 52.9M 14.43M 105.04M 697K 66.02M 67.66M 43.91M 24.77M
Net Cash Flow -29.75M -7.4M -24.63M 48.51M 52.77M -33.3M 11.96M 25.88M 16.76M 8.54M
Free Cash Flow -51.37M -32.83M -61.47M 34.07M -51.48M -60.05M -52.77M -20.27M -23.63M -12.91M